Frederick, MD., Aug. 14, 2024 -- Veralox Therapeutics, a clinical-stage biotechnology company developing first-in-class therapies targeting the 12-lipoxygenase (12-LOX) pathway, announced that the European Medicines Agency (EMA) has granted Orphan...
IlluminOss Medical introduces bone stabilization system in Spain, Israel
IlluminOss Medical has launched its Photodynamic Bone Stabilization System, a percutaneous, patient-specific orthopedic implant system for the stabilization and treatment of bone fractures, in Spain and Israel.
Source: www.healio.com
